Primary Site >> Liver Cancer
Gene >> MAP2K3
| 1. | |||||||||||
| Journal: | BMC Cancer. 2013 Oct 10;13:469. | ||||||||||
| Title: | MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3. | ||||||||||
| Author: | Xu, Guangxian|Zhang, Yilin|Wei, Jun|Jia, Wei|Ge, Zhaohui|Zhang, Zhaobo|Liu, Xiaoming | ||||||||||
| PMID: | 24112539 | ||||||||||
| 2. | |||||||||||
| Journal: | Oncotarget. 2015 Dec 8;6(39):41722-35. | ||||||||||
| Title: | Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling. | ||||||||||
| Author: | Lu, Wen-Jing|Chua, Mei-Sze|So, Samuel K | ||||||||||
| PMID: | 26497681 | ||||||||||
| 3. | |||||||||||
| Journal: | Mol Med Rep. 2016 Jan;13(1):243-8. | ||||||||||
| Title: | Mitogen-activated protein kinase kinase 3 induces cell cycle arrest via p38 activation mediated Bmi-1 downregulation in hepatocellular carcinoma. | ||||||||||
| Author: | Wang, Lin|Chen, Chen|Feng, Shuzhi|Lei, Ping|Tian, Jianli | ||||||||||
| PMID: | 26573508 | ||||||||||
| 4. | |||||||||||
| Journal: | Oncotarget. 2016 Mar 8;7(10):11284-98. | ||||||||||
| Title: | SIRT1 increases YAP- and MKK3-dependent p38 phosphorylation in mouse liver and human hepatocellular carcinoma. | ||||||||||
| Author: | Wang, Yulan|Cui, Ran|Zhang, Xiao|Qiao, Yongxia|Liu, Xiangfan|Chang, Yefei|Yu, Yongchun|Sun, Fenyong|Wang, Jiayi | ||||||||||
| PMID: | 26824501 | ||||||||||
| 5. | |||||||||||
| Journal: | Yonsei Med J. 2017 Sep;58(5):899-909. | ||||||||||
| Title: | Down-Regulation of TGF-beta Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib. | ||||||||||
| Author: | Kang, Dongxu|Han, Zhezhu|Oh, Geun Hyeok|Joo, Yeonsoo|Choi, Hye Jin|Song, Jae J | ||||||||||
| PMID: | 28792132 | ||||||||||
| 6. | |||||||||||
| Journal: | Apoptosis. 2017 Nov;22(11):1362-1379. | ||||||||||
| Title: | Modulation of adenylate cyclase signaling in association with MKK3/6 stabilization under combination of SAC and berberine to reduce HepG2 cell survivability. | ||||||||||
| Author: | Sengupta, Dipanwita|Chowdhury, Kaustav Dutta|Chatterjee, Sujan|Sarkar, Avik|Paul, Soumosish|Sur, Pradip Kumar|Sadhukhan, Gobinda Chandra | ||||||||||
| PMID: | 28836036 | ||||||||||